摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(Piperazine-1-sulfonyl)isoquinoline dihydrochloride | 210297-47-5

中文名称
——
中文别名
——
英文名称
5-(Piperazine-1-sulfonyl)isoquinoline dihydrochloride
英文别名
5-piperazin-1-ylsulfonylisoquinoline;dihydrochloride
5-(Piperazine-1-sulfonyl)isoquinoline dihydrochloride化学式
CAS
210297-47-5
化学式
C13H17Cl2N3O2S
mdl
MFCD01310980
分子量
350.3
InChiKey
ZKQAPKKKTQCVKG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    不溶于乙醇;水中≥131.8 mg/mL;超声波检测下 DMSO 中≥19.17 mg/mL

计算性质

  • 辛醇/水分配系数(LogP):
    0.26
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.307
  • 拓扑面积:
    70.7
  • 氢给体数:
    3
  • 氢受体数:
    5

制备方法与用途

HA-100 dihydrochloride 是 cGMP-dependent protein kinase (PKG)、cAMP-dependent protein kinase (PKA)、protein kinase C (PKC) 和 MLC-kinase 的抑制剂,对应的IC50值分别为4 μM、8 μM、12 μM和240 μM。
TargetValue
PKG
(Cell-free assay)
4 μM
PKA
(Cell-free assay)
8 μM
PKC
(Cell-free assay)
12 μM
MLCK
(Cell-free assay)
240 μM

文献信息

  • Use of standards for monitoring alterations of peptide and protein samples
    申请人:BioVisioN AG
    公开号:EP1619503A1
    公开(公告)日:2006-01-25
    The present invention is directed to methods of using standards for determining and monitoring alterations and variations of peptide and protein samples. More specifically, the present invention relates to methods of determining and monitoring alterations of the sample quality, in particular after collection, during processing and during storage of the sample.
    本发明涉及使用标准品确定和监测肽和蛋白质样品的变化和变异的方法。更具体地说,本发明涉及确定和监测样品质量变化的方法,特别是在样品采集后、处理过程中和储存期间。
  • USE OF STANDARDS FOR MONITORING ALTERATIONS OF PEPTIDE AND PROTEIN SAMPLES
    申请人:DIGILAB BioVisioN GmbH
    公开号:EP1766416A1
    公开(公告)日:2007-03-28
  • [EN] USE OF STANDARDS FOR MONITORING ALTERATIONS OF PEPTIDE AND PROTEIN SAMPLES<br/>[FR] APPLICATION DE NORMES POUR CONTROLER DES ALTERATIONS D'ECHANTILLONS DE PEPTIDES ET DE PROTEINES
    申请人:BIOVISION AG
    公开号:WO2006005622A1
    公开(公告)日:2006-01-19
    The present invention is directed to methods of using standards for determining and monitoring alterations and variations of peptide and protein samples. More specifically, the present invention relates to methods of determining and monitoring alterations of the sample quality, in particular after collection, during processing and during storage of the sample.
查看更多